116 related articles for article (PubMed ID: 7197958)
1. [Digitoxin plasma concentrations during oral treatment (author's transl)].
Heinz N; Woodcock B
Arzneimittelforschung; 1981; 31(9):1471-3. PubMed ID: 7197958
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
Flasch CI; Heinz N
Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
[TBL] [Abstract][Full Text] [Related]
3. Digitalis therapy in renal failure with special regard to digitoxin.
Vöhringer HF; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
[TBL] [Abstract][Full Text] [Related]
4. [Serial tests of serum-digitoxin levels during digitoxin treatment (author's transl)].
Peters U; Hausamen TU; Grosse-Brockhoff F
Dtsch Med Wochenschr; 1974 Aug; 99(35):1701-7. PubMed ID: 4410846
[No Abstract] [Full Text] [Related]
5. [Interaction of quinidine and digitoxin in the human (author's transl)].
Peters U; Risler T; Grabensee B; Falkenstein U; Kroukou J
Dtsch Med Wochenschr; 1980 Mar; 105(13):438-42. PubMed ID: 7363796
[TBL] [Abstract][Full Text] [Related]
6. [Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop (author's transl)].
Weiss W; Olcay A; Teufel W; Glocke M
Med Klin; 1975 Aug; 70(35):1367-74. PubMed ID: 809651
[TBL] [Abstract][Full Text] [Related]
7. [Kinetics of digitoxin during antirheumatic therapy with azapropazone (author's transl)].
Faust-Tinnefeldt G; Gilfrich HJ
Arzneimittelforschung; 1977; 27(10):2009-11. PubMed ID: 579114
[TBL] [Abstract][Full Text] [Related]
8. [Dosing of digitoxin in clinical practice].
Hønnås A; Reimers A; Spigset O
Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1334-6. PubMed ID: 20596112
[TBL] [Abstract][Full Text] [Related]
9. Measurements of glomerular filtration in the intensive care unit are only a rough guide to renal function.
Wells M; Lipman J
S Afr J Surg; 1997 Feb; 35(1):20-3. PubMed ID: 9164151
[TBL] [Abstract][Full Text] [Related]
10. Digitoxin studies. Serum concentration during digitalization, maintenance therapy and withdrawal. Estimation of proper maintenance dose.
Gjerdrum K
Acta Med Scand; 1972; 191(1-2):25-34. PubMed ID: 4260684
[No Abstract] [Full Text] [Related]
11. Lack of endogenous crossreactivity with three digitoxin radioimmunoassays in adults with renal insufficiency.
Mueller BA; Bussey HI; Casto DT; Lowder NK; Sugarek NJ; Cremer KF
Clin Pharm; 1988 Nov; 7(11):825-8. PubMed ID: 3197382
[TBL] [Abstract][Full Text] [Related]
12. [Serum digitoxin levels in pacemaker patients].
Nobis H; Pollak H; Kalinowski G; Enenkel W; Ogris E
Wien Klin Wochenschr; 1984 Dec; 96(23):843-7. PubMed ID: 6084909
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
Kuhlmann J
Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
[TBL] [Abstract][Full Text] [Related]
15. [Plasma concentration of digoxin and digitoxin in elderly : correlation with clinical toxicity (author's transl)].
Scherrmann JM; Venet R; Maire A; Memin Y; Bourdon R
Therapie; 1981; 36(1):11-20. PubMed ID: 7233367
[No Abstract] [Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
17. Digitoxin plasma half-life in the dog after administration of toxic doses.
Bluschke V; Viana AP
Arzneimittelforschung; 1976 Apr; 26(4):591-2. PubMed ID: 989016
[TBL] [Abstract][Full Text] [Related]
18. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
19. [Determination of serum digitoxin by means of a solid-phase enzyme-linked immunosorbent assay (author's transl)].
Belz GG; Belz G
Med Klin; 1979 Apr; 74(16):620-3. PubMed ID: 111013
[TBL] [Abstract][Full Text] [Related]
20. [Clinical pharmacokinetics and practical consequences of optimal use of medroxyprogesterone acetate].
Etienne MC; Milano G; Namer M
Bull Cancer; 1993 May; 80(5):431-8. PubMed ID: 8173196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
